Insulet
PODD
#1966
Rank
NZ$18.20 B
Marketcap
NZ$262.40
Share price
-6.16%
Change (1 day)
-53.91%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): NZ$2.81

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$7.58. In 2022 the company made an earnings per share (EPS) of NZ$0.13 a decrease over its 2021 EPS that were of NZ$0.41.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$2.812138.86%
2022NZ$0.13-69.57%
2021NZ$0.41109.09%
2020NZ$0.20-38.89%
2019NZ$0.32200%
2018NZ$0.11-113.04%
2017NZ-$0.82-9.8%
2016NZ-$0.91-60.77%
2015NZ-$2.3339.78%
2014NZ-$1.6712.05%
2013NZ-$1.49-23.15%
2012NZ-$1.9310.2%
2011NZ-$1.76-36.36%
2010NZ-$2.76-36.63%
2009NZ-$4.35-29.36%
2008NZ-$6.16-86.74%
2007NZ-$46.47-64.04%
2006NZ-$129.22122.23%
2005NZ-$58.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.97 58.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.84-36.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.31-3.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$55.28 629.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$1.67-121.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$2.15-71.63%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.64-38.77%๐Ÿ‡บ๐Ÿ‡ธ USA